Ikonisys S.A. (EPA:ALIKO)

Market Cap	22.44M
Revenue (ttm)	1.47M
Net Income (ttm)	-2.86M
Shares Out	14.02M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,493
Average Volume	16,233
Open	1.600
Previous Close	1.600
Day's Range	1.600 - 1.680
52-Week Range	1.280 - 1.780
Beta	0.70
RSI	56.96
Earnings Date	Apr 29, 2026

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 15
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIKO

Financial Performance

In 2024, Ikonisys's revenue was 1.01 million, an increase of 56.72% compared to the previous year's 645,173. Losses were -3.24 million, 42.9% more than in 2023.